Combined Oxidative Phosphorylation Defect Type 15

Combined oxidative phosphorylation defect type 15 is a very rare inherited disease that affects how the “power stations” of the cell, called mitochondria, make energy. In this condition, a gene called MTFMT does not work properly, so the cell cannot correctly start building some of the proteins needed for the oxidative phosphorylation (OXPHOS) system, which is the final step of energy production. As a result, tissues that need a lot of energy – especially the brain and muscles – do not get enough ATP, and children develop problems such as low muscle tone, unsteady walking, developmental delay, learning difficulties, and sometimes features similar to Leigh syndrome, a serious childhood brain disease.[1][2][3]

Combined oxidative phosphorylation defect type 15 (COXPD15) is a very rare genetic mitochondrial disease. In this condition, the tiny “power stations” inside cells, called mitochondria, cannot make enough energy using a process called oxidative phosphorylation. The problem usually comes from a change (mutation) in a gene called MTFMT, which helps build mitochondrial proteins needed for energy production.[1]

Children with combined oxidative phosphorylation defect type 15 often have symptoms in infancy or early childhood. They may have poor muscle tone (hypotonia), trouble with balance and walking (ataxia), slow development, speech and learning difficulties, and changes seen on brain scans similar to Leigh syndrome, which is a severe neuro-metabolic disorder.[2]

Other names

Doctors and researchers may use several different names for the same condition, which can be confusing. “Combined oxidative phosphorylation defect type 15” and “combined oxidative phosphorylation deficiency 15” are the most common names and both are usually shortened to COXPD15.[1][2][4]

Sometimes the disease is also described as “combined oxidative phosphorylation deficiency caused by mutation in MTFMT,” which stresses the faulty gene. You may also see it written simply as “MTFMT combined oxidative phosphorylation deficiency” or “COXPD15 – combined oxidative phosphorylation defect type 15” in genetic test reports and rare-disease databases.[1][2][3]

Types

Because this is a very rare disease, there is no rigid official subtype system like “type A, type B.” However, doctors often group patients by how and when the symptoms appear. One practical way is to think in terms of clinical patterns, rather than strict genetic subtypes.[1][3][5]

• Infant-onset neurodevelopmental type – Some children show low muscle tone (“floppy baby”), poor head control, feeding difficulties, and developmental delay in the first year of life. Later they may develop ataxia (unsteady movements) and learning problems.[1][3]

• Childhood-onset ataxic type – Other children develop apparently normally at first and then, in early childhood, begin to show unsteady gait, clumsiness, problems with coordination, and difficulty with school tasks such as reading or writing, along with mild intellectual disability.[1][2][3]

• Leigh-like encephalopathy type – A smaller group have brain MRI changes and symptoms that look similar to Leigh syndrome, such as lesions in the basal ganglia and brainstem, episodes of regression, and sometimes seizures or breathing problems. This “Leigh-like” picture is still due to the same underlying MTFMT-related energy defect.[1][2][4]

Causes

In simple terms, the main cause of COXPD15 is having two faulty copies of the MTFMT gene. All other “causes” listed below are better understood as types of mutation, inheritance patterns, or factors that increase risk or worsen the disease, but the core problem is the same: impaired mitochondrial protein synthesis and oxidative phosphorylation.

1. Biallelic pathogenic variants in MTFMT – COXPD15 happens when a child inherits two disease-causing changes (variants) in the MTFMT gene, one from each parent. With both copies affected, the enzyme methionyl-tRNA formyltransferase cannot work properly, so mitochondrial protein synthesis and energy production are disturbed.[1][2][3][4]

2. Autosomal recessive inheritance – The condition follows an autosomal recessive pattern, which means parents are usually healthy carriers with one normal copy and one altered copy of MTFMT. When both parents are carriers, each child has a 25% chance to have COXPD15, a 50% chance to be a carrier, and a 25% chance to inherit two normal copies.[2][3][11]

3. Missense mutations in MTFMT – Some variants change one amino acid in the enzyme (missense). This can reduce enzyme activity, alter stability, or disturb how it interacts with mitochondrial tRNA, leading to partial but significant loss of function and energy deficiency.[2][4][17]

4. Nonsense and frameshift mutations – Other variants introduce a premature stop signal or shift the reading frame. These changes often create a truncated protein that is quickly broken down by the cell, leaving little or no functional MTFMT enzyme.[2][4]

5. Splice-site mutations – Some disease-causing changes occur at splice sites, the regions that tell the cell how to cut and join RNA pieces. Faulty splicing can remove important exons or insert extra sequences, producing a non-functional enzyme and disturbing mitochondrial translation.[2][11]

6. Small deletions or duplications in MTFMT – Copy-number changes, where small sections of the MTFMT gene are deleted or duplicated, can disrupt the reading frame or remove critical domains, again preventing normal enzyme function and OXPHOS activity.[11][12]

7. Defective mitochondrial protein synthesis – Regardless of the exact DNA change, MTFMT dysfunction means the very first step of mitochondrial protein building (adding a formyl group to methionyl-tRNA) is impaired. This slows or blocks the production of proteins in respiratory chain complexes, causing combined oxidative phosphorylation deficiency in many tissues.[4][17][18]

8. High energy demand in brain and muscles – The brain, especially the basal ganglia and brainstem, and skeletal muscles need constant high energy. In COXPD15, limited ATP supply in these organs leads to early symptoms such as hypotonia, ataxia, and developmental delay, and to characteristic MRI changes.[1][2][3]

9. Genetic background in other mitochondrial genes – Variants in other nuclear or mitochondrial genes may not cause COXPD15 by themselves but can modify how severe the disease is. For example, additional mild defects in respiratory chain assembly or antioxidant systems can further reduce energy production.[5][18]

10. Consanguinity (parents related by blood) – In some reported families, the parents are related (such as cousins). When families share more ancestors, they are more likely to carry the same rare MTFMT variant, increasing the chance that a child receives two altered copies.[2][14]

11. De novo variants (rare) – Although most cases come from carrier parents, occasional de novo (new) variants can occur in the egg or sperm. These arise spontaneously and are not inherited from either parent, but they can still disrupt MTFMT function if they hit important regions of the gene.[11][18]

12. Intercurrent infections and fever – In many mitochondrial diseases, infections and high fever increase metabolic demand. When the body needs more energy, the underlying OXPHOS defect becomes more obvious, sometimes triggering regression, worsening ataxia, or episodes of lactic acidosis in a child with COXPD15.[1][5]

13. Metabolic stress such as fasting or dehydration – Long periods without food, severe vomiting, or dehydration can push the body into a “catabolic” state, where it breaks down its own tissues for energy. This adds extra stress to already weak mitochondria and may trigger acute worsening of symptoms.[5][18]

14. Possible nutritional deficiencies – While not a direct cause of COXPD15, lack of vitamins such as folate, vitamin B12, or other cofactors needed for mitochondrial metabolism may worsen the energy shortage and make symptoms more severe in affected children.[5][18]

15. Exposure to mitochondrial-toxic medicines – Some drugs (for example, certain antiepileptics or antibiotics) can further impair mitochondrial function. In a child with COXPD15, these medicines may lower energy production even more and aggravate neurological symptoms.[5][18]

16. Perinatal hypoxia or birth complications – Lack of oxygen around the time of birth does not cause the gene defect but can injure the vulnerable brain. When combined with COXPD15, such injuries may lead to more obvious developmental delay or movement problems.[5]

17. Coexisting mitochondrial DNA variants – Some patients may carry additional variants in mitochondrial DNA that affect respiratory chain complexes. Alone, these might be mild, but together with MTFMT mutations they can deepen the OXPHOS defect and widen the clinical picture.[5][18]

18. Delayed diagnosis and lack of supportive care – When the condition is not recognized early, children may not receive helpful therapies such as physiotherapy, seizure control, nutritional support, and careful management of infections, allowing symptoms to progress faster.[1][3]

19. Unknown genetic modifiers – Because few patients have been described, scientists believe additional, still-unknown genes may influence how severe COXPD15 becomes. These modifiers may affect mitochondrial quality control, antioxidant defense, or brain development.[2][11]

20. Unclear environmental factors – It is possible that yet-unidentified environmental factors, such as chronic poor nutrition or repeated severe infections, could influence the course of the disease, but current evidence is limited and research is ongoing.[5][18]

Symptoms

Not every child has all symptoms, and the severity can differ widely, even within one family. However, the following features are commonly reported.

1. Generalized muscular hypotonia (floppy muscles) – Many babies and young children with COXPD15 feel “floppy” when held, with poor head and trunk control because their muscles are weak and lack normal tension. This low tone reflects the reduced ability of muscle cells to produce energy for sustained contraction.[1][2][3]

2. Gait ataxia (unsteady walking) – As children grow and try to walk, they may stagger, wobble, or have a wide-based gait. This happens because the parts of the brain that control balance and coordination (cerebellum and related pathways) are highly sensitive to mitochondrial energy failure.[1][2][3]

3. Mild pyramidal signs and spasticity – Some children show increased reflexes, stiffness, or scissoring of the legs, which are signs that the long motor pathways from the brain (pyramidal tracts) are affected. These “upper motor neuron” findings can coexist with low muscle tone in mitochondrial disorders.[1][3][4]

4. Global developmental delay – Children may sit, stand, or walk later than expected, and have difficulty with fine motor skills, such as using utensils or drawing. The brain’s limited energy supply slows the maturation of many networks needed for movement, coordination, and problem-solving.[1][2][3]

5. Speech and language delay – Many affected children have difficulty learning to speak, forming clear words, or understanding complex instructions. This may reflect both muscle coordination problems (dysarthria) and cognitive challenges, since speech networks are energy-demanding.[1][2][3]

6. Intellectual disability or learning difficulties – School-age children often struggle with attention, memory, and processing speed, leading to mild or moderate intellectual disability. They may need special education support, and their abilities may plateau or decline if metabolic crises occur.[1][2][16]

7. Short stature – Some patients are shorter than expected for their age and family height. Chronic energy deficiency can affect growth hormone pathways and the growth plates in bones, leading to reduced linear growth over time.[2][3][16]

8. Obesity or increased body weight – Interestingly, some children with COXPD15 develop obesity or are heavier than average, despite muscle weakness. This may relate to low physical activity, altered energy balance, and possible hypothalamic involvement affecting appetite and metabolism.[2][16]

9. Microcephaly (small head size) – A smaller-than-average head circumference in some patients suggests reduced brain growth. Persistent energy shortage during brain development can limit the formation of new connections and lead to microcephaly.[2][3][16]

10. Nystagmus (involuntary eye movements) – Rapid, jerky eye movements may appear, especially when looking to the side. Nystagmus often indicates involvement of the brainstem or cerebellum, both of which are affected in many mitochondrial and Leigh-like disorders.[1][2][3]

11. Strabismus (squint) and eye alignment problems – One eye may turn inward, outward, up, or down compared with the other. Energy failure in the nerves and muscles that move the eyes can cause misalignment, leading to double vision or reduced depth perception if untreated.[1][2][16]

12. Reduced visual acuity – Some children have poor sharpness of sight or difficulty seeing detail, possibly from retinal involvement, optic nerve problems, or long-standing misalignment. Because the visual system is highly energy-dependent, mitochondrial defects can gradually impair vision.[1][2][3]

13. Seizures – A proportion of patients experience epileptic seizures, which may present as staring spells, jerking movements, or loss of consciousness. Seizures reflect abnormal electrical activity in the brain and can be triggered or worsened by metabolic stress.[2][3][16]

14. Lactic acidosis episodes – Laboratory tests often show raised lactic acid in blood or cerebrospinal fluid, and children may have episodes with vomiting, rapid breathing, and extreme tiredness. Lactic acidosis occurs when cells switch to less efficient energy pathways because mitochondria cannot keep up.[1][2][12]

15. Chronic fatigue and poor exercise tolerance – Even without acute crises, many children tire quickly with physical activity, cannot keep up with peers, and may need frequent rests. This is a direct result of reduced ATP production in muscle and nerve cells.[1][2][5]

Diagnostic tests –

Physical examination

1. Comprehensive pediatric and neurological examination – The doctor carefully checks head control, muscle tone, reflexes, strength, coordination, and developmental level. In COXPD15 they often find low muscle tone, brisk reflexes, unsteady movements, and delayed milestones, raising suspicion of a mitochondrial or Leigh-like disorder.[1][2][3]

2. Growth and nutritional assessment – Measuring weight, height, body mass index, and head circumference over time helps identify short stature, obesity, or microcephaly, which are described in this condition. These measurements also guide nutritional support and monitoring.[2][3][16]

3. Gait and coordination evaluation – Observation of how the child sits, stands, and walks, and simple tasks like touching a finger to the nose, can show ataxia and clumsiness. These bedside tests are important to document severity and progression of cerebellar and pyramidal involvement.[1][2][3]

4. Eye and vision examination at the bedside – Basic checks of eye movements, alignment, and visual tracking can reveal nystagmus, strabismus, or reduced visual response. Abnormal findings prompt referral to an ophthalmologist for more detailed testing.[1][2][3]

Manual and functional tests

5. Manual muscle strength testing – The clinician asks the child to push or pull against resistance with arms and legs, grading strength on a simple scale. In COXPD15, strength may be mildly to moderately reduced, especially in muscles that are used all day like the hips and shoulders.[1][3][5]

6. Balance tests such as Romberg and tandem walking – Standing with feet together, standing with eyes closed, or walking heel-to-toe help reveal balance problems. Children with mitochondrial ataxia often sway, step widely, or lose balance on these tasks.[1][2][5]

7. Developmental and functional skill scales – Simple standardized tools or play-based tasks are used to assess speech, fine motor skills, social interaction, and daily living abilities. These scales help quantify developmental delay and guide therapies such as physiotherapy and speech therapy.[1][3][16]

Laboratory and pathological tests

8. Serum lactate and pyruvate levels – Blood tests often show increased lactic acid, sometimes with altered pyruvate, suggesting impaired oxidative phosphorylation. Persistent or stress-induced lactic acidosis is a strong biochemical clue pointing toward mitochondrial disease such as COXPD15.[1][2][12]

9. Blood gas and basic metabolic panel – Measuring pH, bicarbonate, electrolytes, and kidney function helps detect metabolic acidosis and other imbalances during illness. These tests are essential to manage acute episodes safely and to distinguish mitochondrial crises from other metabolic conditions.[5][18]

10. Creatine kinase and liver function tests – Mild elevation of muscle enzymes or liver markers may occur in mitochondrial disease. While not specific for COXPD15, these tests provide supportive evidence of muscle or liver stress and help rule out other causes of weakness.[5][18]

11. Plasma and cerebrospinal fluid amino acids and organic acids – Specialized metabolic tests look for patterns typical of mitochondrial dysfunction, such as elevated alanine or certain organic acids. Abnormal profiles can support the diagnosis and help exclude other inborn errors of metabolism.[5][18]

12. Targeted genetic testing for MTFMT – Once clinical and biochemical findings suggest a mitochondrial disorder, DNA sequencing of the MTFMT gene can confirm COXPD15 by identifying disease-causing variants. This test also allows carrier testing and family counseling.[2][11][12]

13. Mitochondrial or neuro-metabolic gene panels / exome sequencing – In many centers, broad gene panels or whole exome sequencing are used when the diagnosis is uncertain. These methods can detect MTFMT variants along with changes in other mitochondrial genes, giving a fuller picture of the child’s genetic risks.[2][11][16]

14. Muscle biopsy with histology and respiratory chain enzymology – In selected cases, a small sample of muscle is examined under the microscope and tested for activity of respiratory chain complexes. Findings such as reduced activities of multiple complexes and ragged-red fibers can support a diagnosis of combined oxidative phosphorylation deficiency.[5][18]

Electrodiagnostic tests

15. Electroencephalogram (EEG) – EEG records the brain’s electrical activity and is used when seizures or episodes of unresponsiveness occur. In COXPD15, EEG may show generalized or focal epileptic discharges, helping guide anti-seizure treatment and monitor disease progression.[2][3][16]

16. Nerve conduction studies and electromyography (EMG) – These tests measure how fast and how strongly nerves and muscles respond to electrical stimulation. They can help distinguish primary muscle disease, neuropathy, or central motor problems; in many mitochondrial disorders they may be normal or show only mild changes.[5][18]

17. Evoked potentials (visual or auditory) – By measuring brain responses to visual flashes or sound clicks, doctors can detect slowed conduction along pathways affected by mitochondrial dysfunction. Abnormal evoked potentials may correlate with visual problems or hearing involvement.[5][18]

Imaging tests

18. Brain MRI – Magnetic resonance imaging is one of the most important tests in COXPD15. It often shows T2-weighted hyperintensities (bright areas) in the basal ganglia, corpus callosum, or brainstem, a pattern similar to Leigh syndrome and other mitochondrial encephalopathies.[1][2][4]

19. Magnetic resonance spectroscopy (MRS) – MRS is an MRI technique that can measure brain metabolites, such as lactate and N-acetylaspartate. Elevated lactate or reduced markers of healthy neurons provide direct evidence of mitochondrial energy failure in brain tissue.[5][18]

20. Echocardiography (heart ultrasound) – Although severe cardiomyopathy is less prominent in reported COXPD15 cases than in some other OXPHOS disorders, heart ultrasound is often done to check heart structure and function. Detecting early cardiac involvement allows closer monitoring and timely treatment if needed.[2][5][12]

Non-Pharmacological Treatments (Therapies and Other Approaches)

Below are 20 non-drug approaches. Most are used together as a “bundle of care”. Evidence is limited, but they are commonly used in mitochondrial and neuro-developmental disorders under specialist guidance.[5]

1. Physiotherapy and motor training
   Physiotherapy helps keep joints flexible, muscles strong, and posture better. The therapist uses gentle stretches, balance exercises, and walking practice. The purpose is to slow muscle weakening, reduce contractures, and improve sitting, standing, and walking safety. The mechanism is simple: regular, low-to-moderate exercise trains muscles to use energy more efficiently without over-stressing damaged mitochondria. Sessions are carefully paced so the child does not become exhausted, because over-exercise can worsen fatigue.[6] [1]

2. Occupational therapy (OT)
   Occupational therapists help children manage daily tasks such as dressing, feeding, writing, and using assistive tools. The purpose is to support independence and school participation. OT works by breaking tasks into small steps, teaching energy-saving strategies, and adapting tools (special cutlery, pencil grips, seating). This reduces the energy demand for each activity, which is important when cells cannot make energy well, as in combined oxidative phosphorylation defect type 15.[2]

3. Speech and language therapy
   Children may have difficulty speaking clearly or understanding language. Speech therapists work on articulation, vocabulary, and communication strategies. The purpose is to improve communication and learning. The mechanism is repeated practice of speech muscles and language skills with visual aids and alternative communication systems (pictures, devices) to bypass some of the motor and coordination problems caused by low energy in brain cells.[3]

4. Neuro-developmental and special education support
   Special education teachers design learning programs that match the child’s level and pace. The purpose is to support cognitive development despite brain involvement. The mechanism is to provide structured, repeated learning with breaks, simple instructions, and multi-sensory teaching, which reduces energy load on the brain and helps memory in children with mitochondrial disease.[4]

5. Energy-conservation and fatigue-management training
   Occupational therapists and nurses teach the child and family how to plan the day: spreading tasks, taking regular rests, and avoiding long periods of intensive activity. The purpose is to reduce exhaustion and crashes. Mechanistically, this lowers the peak energy demand on mitochondria, which may help avoid lactic acid build-up and worsening weakness.[5]

6. Nutritional counselling and high-energy diet planning
   Dietitians plan a diet with enough calories and protein to support growth and repair while avoiding prolonged fasting. The purpose is to prevent malnutrition and catabolism, which seriously stress mitochondrial function. The mechanism is to provide frequent meals and snacks, sometimes with extra complex carbohydrates and healthy fats, so cells always have fuel and do not need to break down body tissues excessively.[6]

7. Swallowing therapy and feeding strategies
   If swallowing is weak or uncoordinated, speech therapists and dietitians teach special feeding positions, textures, and pacing to reduce choking risk. The purpose is safe feeding and better nutrition. This works by matching food textures and swallowing exercises to the child’s neuromuscular ability, lowering the risk of aspiration pneumonia, which is a serious complication in mitochondrial diseases.[7]

8. Respiratory physiotherapy
   Some children have weak breathing muscles. Respiratory therapy includes breathing exercises, cough-assist devices, and chest physiotherapy. The purpose is to keep lungs clear and reduce infections. Mechanistically, these techniques help move mucus, improve ventilation, and compensate for muscle weakness so oxygen supply to tissues is better despite mitochondrial problems.[8]

9. Assistive devices for mobility
   Walkers, wheelchairs, orthotic braces, and standing frames can be used when gait is unsafe or very tiring. The purpose is to keep the child mobile, safe, and engaged with family and school. The mechanism is mechanical support and energy saving for weak muscles, so the child can travel longer distances and participate without over-using their limited energy.[9]

10. Vision and hearing support
    If there are vision or hearing problems, glasses, low-vision aids, and hearing devices are used. The purpose is to improve communication and safety. Mechanistically, correcting sensory input reduces brain effort needed to process unclear signals, which is helpful in a brain already stressed by low energy.[10]

11. Psychological and family counselling
    Living with a chronic rare disease is very stressful. Psychologists provide emotional support, coping strategies, and help with anxiety or low mood. The purpose is to protect mental health of the child and family. This works by giving space to express feelings, teaching problem-solving, and connecting families with support groups for mitochondrial disorders.[11]

12. Seizure-safety education and home plans
    If the child has seizures, families are taught how to recognize warning signs, keep the child safe, and when to call emergency services. The purpose is to reduce injury and delays in treatment. The mechanism is early action to limit prolonged seizures, which can further damage already fragile brain tissue in combined oxidative phosphorylation defect type 15.[12]

13. Infection-prevention routines
    Good handwashing, vaccination according to specialist advice, and quick treatment of infections are important. The purpose is to avoid fever and illness that can trigger metabolic crises. The mechanism is simply reducing triggers that increase energy demand and lactic acid production in damaged mitochondria.[13]

14. Avoidance of known mitochondrial toxins
    Some medicines and exposures can stress mitochondria (for example, certain antibiotics or valproate in some patients). Specialists provide a “safe drug list”. The purpose is to prevent sudden worsening. Mechanistically, avoiding additional mitochondrial poisons prevents further inhibition of oxidative phosphorylation on top of the genetic defect in COXPD15.[14]

15. Temperature and stress management
    Very high or very low body temperature and severe emotional or physical stress can worsen symptoms. Families are advised to keep the child comfortable, avoid prolonged heat, and manage stress. The mechanism is to limit sudden changes in metabolic rate, thereby avoiding sudden increases in energy demand that mitochondria cannot meet.[15]

16. Sleep hygiene and night-time support
    Good sleep schedules, quiet dark rooms, and sometimes respiratory support at night are used. The purpose is to improve daytime energy, mood, and brain function. Mechanistically, deep, good-quality sleep allows better restoration and may reduce seizure risk and fatigue in children with mitochondrial disease.[16]

17. Palliative care and symptom relief planning
    For severe cases, palliative teams help manage pain, breathing problems, and comfort. The purpose is to maximize quality of life even when disease is advanced. Mechanistically, careful symptom control, including non-drug measures, reduces distress and improves sleep and family coping, even if the underlying mitochondrial defect cannot be cured.[17]

18. Genetic counselling for the family
    Because combined oxidative phosphorylation defect type 15 is usually autosomal recessive, parents and siblings may want to understand their carrier risk. Genetic counsellors explain inheritance, testing options, and family planning choices. The mechanism is education and informed decision-making, which can reduce anxiety and help plan for future pregnancies.[18]

19. Social work and disability support services
    Social workers help families access disability benefits, school accommodations, and respite care. The purpose is to lower the practical burden of long-term care. This support mechanism reduces caregiver burnout and helps maintain a stable environment for the child.[19]

20. Participation in registries and research studies
    Because COXPD15 is extremely rare, families may be invited to join mitochondrial disease registries and observational studies. The purpose is to help future research and sometimes gain access to expert centers. The mechanism is collection of standardized data that can guide development of better therapies over time.[20]

---

Drug Treatments

There are no drugs specifically approved by the FDA only for combined oxidative phosphorylation defect type 15. Most medicines used are supportive and often off-label but are based on general mitochondrial disease practice and FDA-approved products for other indications. Doses for children must always be set by a specialist.[21]

1. Levocarnitine (CARNITOR)
   Levocarnitine is a naturally occurring compound that helps transport long-chain fatty acids into mitochondria so they can be burned for energy. FDA-approved labels describe its use in inborn errors of metabolism and dialysis-related carnitine deficiency.[1] In COXPD15, some specialists use it off-label if low carnitine is found, aiming to improve fat energy use and reduce toxic acyl-compounds. Typical adult oral label doses are about 990 mg two or three times daily, but pediatric and mitochondrial doses are individualized. Side effects can include diarrhea and fishy body odor, and it must be used under close medical supervision.[1] [2]

2. Riboflavin (Vitamin B2, including riboflavin 5´-phosphate)
   Riboflavin is a key part of flavin coenzymes (FMN and FAD) used in many mitochondrial enzymes. FDA documents list riboflavin as generally recognized as safe (GRAS) and as a component of some intravenous and oral products.[2] In mitochondrial disorders, riboflavin is used off-label in “mitochondrial cocktails” to support complex I and II function. Adult label doses in some products are around 1–35 mg daily, but mitochondrial specialists often use higher doses; exact dosing and duration are decided individually. Side effects are usually mild (bright yellow urine, rare stomach upset).[3] [3]

3. Thiamine (Vitamin B1)
   Thiamine is another B vitamin that helps enzymes in carbohydrate metabolism and the pyruvate dehydrogenase complex. FDA-approved products include thiamine in multivitamin and nutritional solutions. In mitochondrial disease, high-dose thiamine is sometimes used off-label, especially when lactic acidosis or certain genetic defects are present.[4] Mechanistically, thiamine can help move pyruvate into the Krebs cycle, possibly lowering lactic acid levels. Label adult doses are usually in the tens of milligrams, but mitochondrial doses can be higher and must be guided by a specialist. Side effects are uncommon but can include allergy reactions in rare cases.[4]

4. Biotin (Vitamin B7)
   Biotin is used in some treatable mitochondrial-related disorders, such as biotin–thiamine responsive basal ganglia disease, where it can clearly improve symptoms when started early.[5] In general mitochondrial practice, biotin may be included in vitamin combinations because it supports carboxylase enzymes. Typical doses vary widely, and high doses are always supervised by specialists because they can interfere with some lab tests (like thyroid tests). Side effects are rare but may include mild digestive upset or skin rashes.[5]

5. Coenzyme Q10 (Ubiquinone or Ubiquinol)
   Coenzyme Q10 is part of the mitochondrial electron transport chain and acts as an antioxidant. Dietary supplement fact sheets and reviews show it is widely used for primary mitochondrial disorders, although high-quality evidence is limited and results are mixed.[6] The purpose is to support electron transfer between complexes and reduce oxidative stress. Doses in studies often range from 5–30 mg/kg/day. Side effects can include stomach upset and insomnia in some people. It is generally considered safe but still needs medical supervision.[6]

6. Alpha-lipoic acid
   Alpha-lipoic acid is an antioxidant and cofactor in mitochondrial enzyme complexes. Reviews of mitochondrial therapies list it as a common part of “core supplements”.[7] It aims to reduce oxidative damage and support enzyme activity in the Krebs cycle. Doses vary, and long-term safety data in children are limited. Side effects can include stomach upset, skin rash, or low blood sugar in rare cases. Its use in COXPD15 is off-label and should be guided by a metabolic specialist.[7]

7. Vitamin E (tocopherols)
   Vitamin E is a fat-soluble antioxidant that protects cell membranes from oxidative damage. In mitochondrial disorders, it is sometimes added to supplement regimens to help protect nervous system and muscle cells.[8] Usual doses stay within recommended safety limits because very high doses can increase bleeding risk. The purpose is membrane protection in tissues that are highly sensitive to oxidative stress from defective oxidative phosphorylation. [8]

8. Vitamin C (ascorbic acid)
   Vitamin C is a water-soluble antioxidant. Health-professional fact sheets on mitochondrial disorders list vitamin C as one of the frequently used supplements, though evidence remains limited.[9] It may help recycle other antioxidants and reduce oxidative stress. High doses can cause stomach upset and kidney stone risk in susceptible individuals. In COXPD15, its use is supportive and off-label, and dosing should be planned by a physician.[9]

9. Creatine
   Creatine serves as a rapid energy buffer in muscle and brain cells. In mitochondrial disease, creatine supplements may help improve muscle strength or fatigue in some patients.[10] The mechanism is to store high-energy phosphate groups that can be quickly used when ATP levels drop. Doses in studies often range from 0.1 g/kg/day, but long-term effects in children require careful monitoring. Side effects may include weight gain and stomach discomfort.[10]

10. Arginine or Citrulline
    In some mitochondrial disorders, especially those with stroke-like episodes, arginine and citrulline are used to boost nitric oxide and improve blood flow. While not specific to COXPD15, some clinicians may consider their use in selected cases.[11] They are usually given under strict protocol, with doses based on weight and clinical situation. Side effects can include stomach upset and low blood pressure, so close monitoring is necessary.[11]

11. Folinic acid (active folate)
    Folinic acid may be used when cerebrospinal fluid (CSF) folate deficiency is present or suspected in mitochondrial disease. It supports one-carbon metabolism and DNA repair. Evidence is limited and mixed, but some case series suggest benefit in selected mitochondrial encephalopathies.[12] Doses vary, and side effects are usually mild (GI upset), but treatment must be individualized.[12]

12. Standard anti-seizure medicines
    If the child has epilepsy, standard anti-seizure drugs (like levetiracetam or others) may be used. The choice of medicine is very important because some anti-seizure drugs can worsen mitochondrial function. Specialists choose options thought to be more “mitochondria-friendly”. The purpose is to control seizures and protect brain cells from repeated electrical stress.[13] Side effects depend on the specific drug and dose.[13]

13. Acid-base and lactic acidosis management (e.g., bicarbonate)
    In acute metabolic crises with acidosis, doctors may use intravenous fluids and sometimes sodium bicarbonate or other agents in intensive care. The purpose is to normalize pH and support circulation while the underlying mitochondrial crisis is treated supportively.[14] This is done only in hospital and tailored to blood gas results.[14]

14. Anti-spasticity medicines
    If the child develops spasticity or dystonia, medicines like baclofen or botulinum toxin injections may be used. The purpose is to ease muscle stiffness and improve comfort and function.[15] These drugs act on nerve-muscle communication pathways, not on the mitochondria directly, but they can greatly improve quality of life.[15]

15. Pain-relief medicines (analgesics)
    Some children have headaches, muscle pain, or neuropathic pain. Simple painkillers or neuropathic pain agents are used carefully. The goal is symptom relief while avoiding medicines that may harm mitochondria.[16] Doctors choose the type and dose based on age, weight, and kidney and liver function.[16]

16. Antiemetics and GI motility agents
    Nausea, vomiting, or slow stomach emptying can appear in mitochondrial disease. Medicines to control nausea or improve gut motility may be used. The purpose is to maintain feeding and prevent dehydration and weight loss. They work on gut nerves and receptors to improve movement and reduce nausea sensations.[17]

17. Endocrine and hormone treatments (when needed)
    Some mitochondrial disorders affect hormones like thyroid or growth hormone. If a specific endocrine problem is found, standard hormone replacement (for example, thyroid hormone) may be used according to endocrine guidelines.[18] This helps correct metabolic rate and growth, indirectly supporting energy balance.[18]

18. Antibiotics and antivirals (for infections)
    Infections can quickly worsen mitochondrial disease. Evidence-based, guideline-driven antibiotic or antiviral therapy is used when needed. The purpose is early control of infection and prevention of sepsis. Doctors also try to avoid antibiotics with strong mitochondrial toxicity when possible.[19]

19. Vaccines and immunizations (per specialist advice)
    Vaccines are medicines that help the immune system recognize infections. Most children with mitochondrial disorders are advised to follow immunization schedules, sometimes with extra vaccines like influenza or pneumonia, depending on specialist advice.[20] This reduces infection risk, which in turn lowers metabolic crises. Decisions are always individualized.[20]

20. Clinical-trial or experimental agents
    Some research trials test new drugs aimed at improving mitochondrial function or reducing oxidative stress. These are highly controlled and not routine therapy. Participation is only through specialized centers and ethics-approved studies.[21] They may include small molecules or gene-targeted approaches, but for COXPD15, such options remain experimental.[21]

---

Dietary Molecular Supplements

Many of the “drug” and “supplement” categories overlap. Below are 10 supplements often discussed in mitochondrial disease care. Evidence is variable; use is highly individualized.[1]

1. Coenzyme Q10 [1]

2. Riboflavin (B2) [2]

3. Thiamine (B1) [3]

4. Alpha-lipoic acid [4]

5. Vitamin C [5]

6. Vitamin E [6]

7. Creatine [7]

8. L-carnitine [8]

9. L-arginine or L-citrulline (in selected cases) [9]

10. Multivitamin B-complex tailored to mitochondrial needs [10]

Each of these supplements has a specific function in energy metabolism or antioxidant defense, as described above. However, the exact dose, combination, and duration must be chosen and monitored by a metabolic specialist, because too high doses can cause harm or interact with other medicines.[2]

---

Immunity-Booster / Regenerative / Stem Cell-Related Drug Concepts

Currently, there are no standard stem cell or regenerative drug treatments that are proven and approved specifically for combined oxidative phosphorylation defect type 15. Research is ongoing. Below are 6 concepts sometimes discussed in the scientific literature:[1]

1. Mitochondria-targeted antioxidants (for example, experimental molecules designed to concentrate inside mitochondria) aim to protect mitochondrial membranes from oxidative stress.

2. Gene-targeted therapies (such as future therapies directed at the MTFMT gene) are being researched in the lab, but are not yet available for routine patient care.

3. Hematopoietic stem cell transplantation is used in some other metabolic or immune disorders, but it is not a standard treatment for COXPD15 and would only be considered in very specific research contexts.

4. Cell-based therapies using donor cells with healthy mitochondria are still experimental and mostly at pre-clinical or early clinical stages.

5. Immune-supportive treatments (like standard vaccines or immunoglobulin in defined immune deficiencies) focus on preventing infections, which indirectly protects children with mitochondrial disease.

6. Future combined therapies that pair gene therapy, antioxidants, and metabolic support are being discussed in research, but they are not yet available as regular treatments.

Families should be very cautious about any unregulated “stem cell” or “immune-booster” products marketed online, as many are expensive, untested, and sometimes unsafe.[2]

---

Possible Surgeries

Surgery does not cure combined oxidative phosphorylation defect type 15. However, some surgeries may be needed to manage complications. All surgery decisions require careful risk–benefit analysis by a multi-disciplinary team.[1]

1. Gastrostomy tube (G-tube) insertion – for children who cannot safely eat by mouth or need extra nutrition. It provides a direct route to the stomach so feeding is easier and safer.

2. Orthopedic surgery for contractures or scoliosis – to correct severe joint stiffness or spine curvature that affects sitting, standing, or breathing.

3. Tendon-lengthening procedures – in some children with severe spasticity, to improve limb position and comfort.

4. Airway or breathing-support surgeries – rarely, if structural airway problems exist, surgical correction may improve breathing safety.

5. Device implantation (for example, feeding pumps or port-a-caths) – to allow long-term safe delivery of nutrition or medicines.

The goal of these surgeries is always to improve comfort, feeding, breathing, or mobility, not to fix the underlying mitochondrial defect.[2]

---

Prevention and Risk-Reduction Strategies

We cannot prevent the genetic change once it is present in a child, but we can try to prevent complications and crises.[1]

1. Avoid long fasting; use regular meals and snacks.

2. Treat infections early and follow vaccine schedules advised by your specialist.

3. Avoid known mitochondrial-toxic drugs when there are safer alternatives.

4. Plan rest periods during the day to avoid over-tiredness.

5. Keep good hydration, especially during illness or hot weather.

6. Have an emergency plan (letters, contacts, hospital checklist) for sudden worsening.

7. Attend regular follow-up with metabolic, neurology, and rehabilitation teams.

8. Monitor growth, nutrition, and developmental progress often.

9. Support mental health of the child and caregivers.

10. Use genetic counselling for future pregnancies to understand carrier and recurrence risk.

These steps reduce stress on mitochondria and lower the chance of severe metabolic emergencies.[2]

---

When to See a Doctor Urgently

Families should seek urgent medical help if the child with combined oxidative phosphorylation defect type 15 has:[1]

• Fast or difficult breathing

• High fever or serious infection signs

• New or worsening seizures

• Sudden loss of skills (for example, no longer able to sit or talk as before)

• Severe vomiting, dehydration, or inability to take fluids

• Unusual sleepiness, confusion, or unresponsiveness

Rapid evaluation and treatment can sometimes prevent permanent damage during a metabolic or neurological crisis.[2]

---

Dietary What to Eat and What to Avoid

Because every child is different, diet must be personalized by a dietitian and metabolic doctor. The points below are general ideas used in many mitochondrial disorders.[1]

Often encouraged (“what to eat”)

1. Regular balanced meals with enough calories and protein for growth.

2. Complex carbohydrates (whole grains, fruits, vegetables) for steady energy.

3. Healthy fats (such as olive oil, avocado, some nuts or seeds if safe) to provide dense energy.

4. Adequate fluids (water, oral rehydration solutions during illness) to prevent dehydration.

5. Vitamin- and mineral-rich foods (fruits, vegetables, dairy or dairy alternatives, lean meats or legumes).

Often limited or avoided (“what to avoid”)

1. Long periods without eating, especially overnight, if the doctor recommends bedtime snacks or special feeds.
2. Crash diets, extreme fasting, or very low-carb diets unless specifically ordered by a specialist.
3. Very high sugar drinks and junk foods that give quick energy peaks then crashes.
4. Alcohol and smoking exposure (for older patients and household members) because they can harm mitochondria.
5. Unregulated herbal or “miracle” supplements bought online without the metabolic doctor’s approval.

Diet choices aim to keep a stable energy supply, avoid catabolism, and support antioxidant defenses.[2]

---

FAQs

1. Is combined oxidative phosphorylation defect type 15 curable?
   No. At present there is no cure. Treatment focuses on support, preventing complications, and improving quality of life with therapies, nutrition, and sometimes supplements.[1]

2. Is it inherited?
   Yes. It is usually autosomal recessive, which means a child inherits one non-working gene from each parent, who are usually healthy carriers.[2]

3. Which gene is usually involved?
   Most reports link COXPD15 to changes in the MTFMT gene, which is important for mitochondrial protein synthesis and energy production.[3]

4. What parts of the body are mainly affected?
   The brain and muscles are most affected, leading to movement problems, developmental delay, and sometimes features that look like Leigh syndrome.[4]

5. Can children go to school?
   Many children can attend school with special supports, therapies, and energy-saving strategies. The level of support needed is very individual.[5]

6. Why are supplements used if evidence is limited?
   Because the disease is so rare, large clinical trials are hard to do. Some supplements are biologically plausible and relatively safe, so specialists may use them carefully while explaining the uncertainty.[6]

7. Can exercise help or harm?
   Gentle, well-planned physiotherapy and activity usually help maintain function. Over-exercise that causes exhaustion or severe pain can be harmful, so activity must be carefully balanced.[7]

8. Are vaccines safe for children with this disease?
   In most cases, vaccines are recommended because infections can be dangerous. However, the exact schedule should be confirmed with the child’s specialist team.[8]

9. Can a special diet cure the disease?
   No diet can cure the genetic problem. A carefully planned diet can support energy balance, growth, and overall health, but it cannot fix the underlying mitochondrial defect.[9]

10. Is stem cell therapy a real option now?
    At present, stem cell approaches for COXPD15 are experimental only. They are not established standard care, and families should be cautious about commercial clinics offering them.[10]

11. What is a “mitochondrial cocktail”?
    This is an informal term for combinations of vitamins and supplements (like CoQ10, riboflavin, thiamine, l-carnitine, antioxidants) used in some mitochondrial patients. The exact mix and doses vary and must be designed by a specialist.[11]

12. Why is research so important in this disease?
    Because combined oxidative phosphorylation defect type 15 is extremely rare, every patient’s data can help researchers understand the disease and design better treatments for the future.[12]

13. Can adults develop combined oxidative phosphorylation defect type 15?
    Most reported cases start in infancy or childhood. Adult-onset cases would be unusual, but mitochondrial disorders in general can appear at many ages.[13]

14. Should brothers and sisters be tested?
    Genetic counselling can help decide if and how siblings should be tested, considering their health, age, and family plans.[14]

15. Where can families find more help?
    Families can ask their doctors about national or international mitochondrial disease organizations, patient support groups, and research registries that offer information, community, and sometimes access to clinical trials.[15]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 19, 2025.